As of 2024-12-14, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (855.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 336.28 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -354.5%.
The range of the Relative Valuation is (793.71) - (900.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.5x - 33.3x | 30.8x |
| Forward P/E multiples | 28.1x - 32.4x | 30.8x |
| Fair Price | (793.71) - (900.50) | (855.86) |
| Upside | -336.0% - -367.8% | -354.5% |
| Date | P/E |
| 2024-12-13 | -12.09 |
| 2024-12-12 | -12.23 |
| 2024-12-11 | -12.28 |
| 2024-12-10 | -12.22 |
| 2024-12-09 | -12.43 |
| 2024-12-06 | -11.70 |
| 2024-12-05 | -11.59 |
| 2024-12-04 | -12.17 |
| 2024-12-03 | -11.95 |
| 2024-12-02 | -12.18 |
| 2024-11-29 | -12.24 |
| 2024-11-27 | -12.17 |
| 2024-11-26 | -12.14 |
| 2024-11-25 | -12.09 |
| 2024-11-22 | -11.97 |
| 2024-11-21 | -11.71 |
| 2024-11-20 | -11.64 |
| 2024-11-19 | -11.53 |
| 2024-11-18 | -11.26 |
| 2024-11-15 | -11.52 |
| 2024-11-14 | -12.59 |
| 2024-11-13 | -13.06 |
| 2024-11-12 | -13.11 |
| 2024-11-11 | -13.16 |
| 2024-11-08 | -13.28 |
| 2024-11-07 | -13.41 |
| 2024-11-06 | -13.41 |
| 2024-11-05 | -13.46 |
| 2024-11-04 | -13.27 |
| 2024-11-01 | -13.25 |
| 2024-10-31 | -12.88 |
| 2024-10-30 | -11.89 |
| 2024-10-29 | -11.93 |
| 2024-10-28 | -11.82 |
| 2024-10-25 | -11.51 |
| 2024-10-24 | -11.80 |
| 2024-10-23 | -12.05 |
| 2024-10-22 | -12.22 |
| 2024-10-21 | -12.34 |
| 2024-10-18 | -12.45 |
| 2024-10-17 | -12.37 |
| 2024-10-16 | -11.86 |
| 2024-10-15 | -12.30 |
| 2024-10-14 | -12.26 |
| 2024-10-11 | -12.11 |
| 2024-10-10 | -11.99 |
| 2024-10-09 | -12.18 |
| 2024-10-08 | -12.20 |
| 2024-10-07 | -12.26 |
| 2024-10-04 | -12.36 |